Cargando…
Peptide Characterization and Functional Stability of a Partially Hydrolyzed Whey-Based Formula over Time
Human clinical trials have shown that a specific partially hydrolyzed 100% whey-based infant formula (pHF-W) reduces AD risk in the first yeast of life. Meta-analyses with a specific pHF-W (pHF-W1) confirm a protective effect while other meta-analyses pooling different pHF-W show conflicting results...
Autores principales: | Bourdeau, Tristan, Affolter, Michael, Dupuis, Lénaïck, Panchaud, Alexandre, Lahrichi, Sabine, Merminod, Loraine, Martin-Paschoud, Christine, Adams, Rachel, Nutten, Sophie, Blanchard, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465316/ https://www.ncbi.nlm.nih.gov/pubmed/34578889 http://dx.doi.org/10.3390/nu13093011 |
Ejemplares similares
-
Characterization of an extensively hydrolyzed whey infant formula with a low bitterness
por: Rapp, M, et al.
Publicado: (2013) -
Partially Hydrolysed Whey-Based Infant Formula Improves Skin Barrier Function
por: Holvoet, Sébastien, et al.
Publicado: (2021) -
A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life
por: Billeaud, Claude, et al.
Publicado: (2022) -
A partially hydrolyzed whey formula provides adequate nutrition in high-risk infants for allergy
por: Yang, Jiyeon, et al.
Publicado: (2022) -
A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated meta-analysis
por: Szajewska, Hania, et al.
Publicado: (2017)